Back to Search
JOSHUA POGUE, DMD
DMD
General Practice Dentistry
NPI: 1225558240Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
09484(IA)
Research & Publications (20)
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.
PMID 19104516·Nat Clin Pract Cardiovasc Med·2009
4-observational
Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
PMID 19528133·Clin Trials·2009
4-observational
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
PMID 18819961·Eur Heart J·2009
2-rct
Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.
PMID 19638004·Transpl Infect Dis·2009
5-case
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.
PMID 19506526·J Hypertens·2009
4-observational
Effect of telmisartan on renal outcomes: a randomized trial.
PMID 19451556·Ann Intern Med·2009
4-observational
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
PMID 19336502·N Engl J Med·2009
4-observational
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
PMID 18268075·Diabetes Care·2008
2-rct
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
PMID 18323500·Stroke·2008
2-rct
Telmisartan, ramipril, or both in patients at high risk for vascular events.
PMID 18378520·N Engl J Med·2008
4-observational
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
PMID 18479744·Lancet·2008
4-observational
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
PMID 18707986·Lancet·2008
4-observational
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
PMID 18955670·Circulation·2008
4-observational
Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial.
PMID 18082486·Am Heart J·2008
4-observational
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
PMID 18757085·Lancet·2008
2-rct
Challenges of establishing new antithrombotic therapies in atrial fibrillation.
PMID 17646595·Circulation·2007
6-review
Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
PMID 17719288·Am Heart J·2007
2-rct
Venous thromboembolism in association with features of the metabolic syndrome.
PMID 17846056·QJM·2007
4-observational
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
PMID 17994519·Infect Control Hosp Epidemiol·2007
8-other
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
PMID 18036454·J Am Coll Cardiol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 3878 MIDDLE RD
BETTENDORF, IA 52722 - Phone
- (563) 332-7734
Quick Facts
- NPI
- 1225558240
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile